Skip to Main Content

Try STAT+ TODAY

pain

Most Read

First Opinion Antje M. Barreveld

As a pain specialist, I may have caused more harm by underprescribing opioids

First Opinion Kate M. Nicholson

Another fight for Covid long-haulers: having their pain acknowledged

Health Isabella Cueto

Medical cannabis unlikely to benefit most chronic pain patients, international researchers say

Health Claudia López Lloreda

In the same health system, Black patients are prescribed fewer opioids than white patients

Pharma David Armstrong — ProPublica

Watch: In never-before-seen video, Purdue’s Richard Sackler defends OxyContin marketing

First Opinion Tom Bowen

Five things I wish I knew earlier in my journey with chronic pain

First Opinion Richard A. "Red" Lawhern

Stop persecuting doctors for legitimately prescribing opioids for chronic pain

First Opinion Stefan G. Kertesz and Kate M. Nicholson

No more ‘shortcuts’ in prescribing opioids for chronic pain. Millions of Americans need nuanced care

All Coverage

Health Elissa Welle

Enrollment in medical cannabis programs saw four-fold increase, study finds

In the Lab Jason Mast

In radical claim, study suggests inflammation wards off chronic pain instead of causing it

advertisement

First Opinion Podcast Patrick Skerrett

Listen: How should doctors treat chronic pain in the wake of the opioid crisis?

First Opinion Shravani Durbhakula and Joshua M. Sharfstein

HHS needs to step up so CDC’s new guidelines won’t be ‘a bridge to nowhere’ for most Americans living with chronic pain

The Readout LOUD Adam Feuerstein and Meg Tirrell

Listen: What’s next for Roche, a debate over second boosters, & Vertex’s recent success

Biotech Damian Garde

STAT Plus: Vertex’s non-opioid painkiller meets goals in mid-stage studies

Health Nicholas St. Fleur and Eric Boodman

STAT Plus: STAT+ Conversation: Pain and Promise: Examining a fibromyalgia blood test

A STAT Investigation Eric Boodman

Selling certainty: In a sea of skeptics, this physician was one of fibromyalgia patients' few true allies. Or was he?

Health Tech Maddie Bender

STAT Plus: 5 health tech startups working to address chronic pain without opioids

Health Elizabeth Cooney

STAT Plus: Challenging the link between statins and muscle pain, patients report no difference in aches when taking drug or placebo

Health Elizabeth Cooney

Elective, but not optional: Orthopedic patients eagerly await surgeries delayed by Covid-19

First Opinion Vanila Singh

Misguided federal regulations are likely to cause more pain in people already living with it

In the Lab Sharon Begley

Brain-imaging study shows ‘hot spot’ that may explain why African Americans feel greater pain

First Opinion Daniel S. Goldberg

Pain doesn’t stigmatize people. We do that to each other

First Opinion Nkeiruka Orajiaka

Some kids in pain need opioids. For doctors, that means walking a tightrope

In the Lab Associated Press

U.S. awards $3 million to fill gaps in medical marijuana research

First Opinion Dawn Rae Downton

Who is really behind a proposed new definition of pain?

Health Lauren Joseph

Study: 2% of women have ‘persistent’ opioid use after childbirth

Health Ruth Hailu

‘Sickle cell needs more funding’: An 18-year-old patient advocate calls on Washington to improve children’s health care

Special Report Julie Appleby and Elizabeth Lucas — Kaiser Health News

While addiction crisis raged, many surgeons overprescribed opioids, analysis shows

Special Report Kaiser Health News

How the Kaiser-Johns Hopkins analysis was done

First Opinion Ben Goodwin, Judy Butler and Adriane Fugh-Berman

Industry-funded attacks on the CDC’s opioid prescribing guideline are eroding public health

First Opinion Julia Arnsten

Access to medical cannabis: a new health care disparity

First Opinion William Fleischman and Joseph S. Ross

How Insys undermined an FDA effort to protect the public from dangerous opioids

Biotech Damian Garde

STAT Plus: Disappointing trial results dim hopes for a new class of pain drugs